Why SpaceX stock is down over 3% on Thursday

SpaceX shares dropped more than 3% (around $111.35 in early trading) as investors awaited the delayed Starship test flight, viewed as a key near-term catalyst. The stock fell 6.7% on Wednesday, extending a volatile post-IPO trading stretch since its record-setting debut.

Analysis

This is mostly a timing-and-positioning event, not a durable fundamental reassessment. For a newly public, high-beta name, a postponed marquee catalyst usually hits the multiple harder than the cash-flow model because the shareholder base is still dominated by momentum and event-driven holders rather than long-duration fundamental capital.

The important second-order effect is relative value across the space stack. If execution slips, capital tends to migrate toward public peers with nearer-term revenue visibility and less binary launch-risk; if the test goes well, the entire complex can catch a sympathy bid, but the winner is still likely to be the name with the clearest cadence, not necessarily the one with the loudest story. A successful test also tightens the competitive screws on launch economics, which helps satellite and data-network customers over time but makes moat arguments in adjacent space names harder to defend.

The real risk is a prolonged cadence gap, because that is when the market stops pricing engineering optionality and starts pricing governance, regulatory friction, and capital intensity. Over the next 1-3 months, the key catalyst is a firm new launch window and any evidence that the schedule is slipping from days into quarters; over 6-18 months, the stock will trade on repeatable launch cadence and conversion of hype into backlog, not on a single test. The contrarian view is that some of the bad news may already be in the price, so the better short may be into a fresh delay rather than into a confirmed launch date.

Key Decisions for Investors

• Avoid chasing SPCX until there is a confirmed launch window; the risk/reward is poor while the catalyst remains date-dependent and the stock is still digesting post-IPO flows.
• If holding SPCX, hedge event risk with short-dated downside protection; a failed or materially slipped test could re-rate the name sharply lower over 1-2 sessions.
• Relative-value trade: long RKLB vs short SPCX if the delay extends beyond the current window. The thesis is that capital rotates to the public space name with clearer near-term revenue visibility while SPCX remains binary. Cover the short if SPCX announces a firm date and closes back above its post-IPO range.
• Event-driven only: consider a limited-risk bullish options structure in SPCX only after a confirmed launch date, not before. The upside case is a short-covering squeeze on success; the downside case remains open-ended if the flight disappoints.
• Set a watch item rather than a hard trade: if the next update slips by more than 2-4 weeks, assume the market will start discounting cadence risk, which is the real fundamental issue.